These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6647062)

  • 1. [Preliminary data on the study of various immunologic parameters in hemophilic children].
    Cogliati C; Cordini M; Giulotto P; Garlaschi C; Martelli A; Carnelli V
    Pediatr Med Chir; 1983; 5(3):37-9. PubMed ID: 6647062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of 3 different prophylactic programs in hemophiliac children].
    Carnelli V; Giulotto P; Auriti L; Cultrera S; Bagnato L; Belli M; Borzani M
    Pediatr Med Chir; 1983; 5(3):11-5. PubMed ID: 6647057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Average number of bleeding episodes in hemophilic children of different ages in "on demand" therapy].
    Giulotto P; Martelli A; Cordini M; Bagnato L; Portioli P; Rusconi R
    Pediatr Med Chir; 1983; 5(3):17-19. PubMed ID: 6647058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged bleeding time in children and young adults with hemophilia.
    Buchanan GR; Holtkamp CA
    Pediatrics; 1980 Dec; 66(6):951-5. PubMed ID: 7454486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of hemophilia on the psychomotor development of children].
    Alba AE; Lambert T; Desmarres C; Eudier H; Laurian Y
    Arch Fr Pediatr; 1987 Apr; 44(4):267-70. PubMed ID: 3592915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease.
    Miners AH; Sabin CA; Tolley KH; Lee CA
    J Intern Med; 1998 Dec; 244(6):515-22. PubMed ID: 9893105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients.
    Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; de Vries S; Roosendaal G; van den Berg HM; Lelie PN
    Vox Sang; 1998; 74(4):225-7. PubMed ID: 9691402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of the patient with a coagulation defect in oral and maxillofacial surgery. III. The management of patients in a hypocoagulative state because of a hemophilic-type primary pathology].
    Chiarini L; Bertoldi C; Narni F
    Minerva Stomatol; 1997 Mar; 46(3):115-31. PubMed ID: 9173221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression in children with hemophilic arthropathy and poliomyelitis: a preliminary report.
    Celiker R; Kutsal YG; Oy B; Onur O; Gürgey A
    Turk J Pediatr; 2000; 42(1):27-30. PubMed ID: 10731865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital.
    Angchaisuksiri P; Atichartakarn V; Pathepchotiwong K; Jootar S; Ungkanont A; Chuncharunee S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():152-8. PubMed ID: 7886560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic approach to von Willebrand's disease in childhood].
    Gebauer E; Baklaja R; Gebauer K; Stevanović S
    Med Pregl; 1996; 49(11-12):479-82. PubMed ID: 9019632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of inherited bleeding disorders in pediatrics.
    El-Bostany EA; Omer N; Salama EE; El-Ghoroury EA; Al-Jaouni SK
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):771-5. PubMed ID: 19002043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease.
    Kavakli K; Polat A; Hüseyinof A; Nisli G; Aydinok Y
    Thromb Haemost; 1999 Apr; 81(4):665-6. PubMed ID: 10235463
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of inhibitors and current treatment strategies.
    Kreuz W; Ettingshausen CE; Auerswald G; Saguer IM; Becker S; Funk M; Heller C; Klarmann D; Klingebiel T;
    Haematologica; 2003 Jun; 88(6):EREP04. PubMed ID: 12826530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined clotting factor deficiencies: experience at a single hemophilia treatment center.
    O'Brien SH; Ritchey AK; Ragni MV
    Haemophilia; 2007 Jan; 13(1):26-9. PubMed ID: 17212721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune tolerance induction in hemophilia A: a review.
    Mariani G; Siragusa S; Kroner BL
    Semin Thromb Hemost; 2003 Feb; 29(1):69-76. PubMed ID: 12640568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.